Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  News  >  Companies  >  All News

News : Companies

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors

Life Science Instrumentation Market 2017 - Global Forecast to 2022 - Research and Markets

share with twitter share with LinkedIn share with facebook
share via e-mail
10/26/2017 | 03:12pm CET

The "Life Science Instrumentation Market by Technology (Spectroscopy, Chromatography, Flow Cytometry, NGS, PCR), Application (Research, Clinical), End User (Pharma-Biotech Companies, Food & Beverage Industry, Hospitals) - Global Forecast to 2022" report has been added to Research and Markets' offering.

The Global Life Science Instrumentation Market is Expected to Reach USD 75.24 Billion By 2022 from USD 54.49 Million in 2017, at a CAGR of 6.7%.

Increasing spending on pharmaceutical R&D, growing food safety concerns, availability of public and private funding for life science research, and continuous technological advancements in analytical instruments are some of the key factors driving the growth of this market. However, the high cost of instruments and the dearth of skilled professionals are expected to restrain market growth to a certain extent.

While North America is expected to account for the largest share of the market in 2017, APAC is expected to register the highest growth rate during the forecast period (2017-2022). This is owing to the rising focus of key market players in emerging Asian countries; increasing crop research studies in Asia to feed its growing population; the growing pharmaceutical industry in India and China; the large biomedical industry in Singapore; and rising number of conferences, exhibitions, and meetings on analytical instruments across the region.

Market Dynamics


  • Increasing Spending On Pharmaceutical R&D
  • Growing Food Safety Concerns
  • Technological Advancements in Analytical Instruments
  • Increasing Public-Private Investments in Life Science Research


  • High Cost of Instruments
  • Dearth of Skilled Professionals


  • Growth Opportunities in Emerging Countries
  • Growing Demand for Analytical Instruments And Focus of Key Market Players On Emerging Countries
  • Growth of the Pharmaceutical And Biotechnology Industry
  • Rising Demand for Analytical Instruments in Proteomics
  • Growing Application Horizons of Analytical Instruments


  • Inadequate Infrastructure for Research in Emerging Countries

Company Profiles

  • Agilent Technologies, Inc.
  • Becton, Dickinson And Company
  • Bio-Rad Laboratories, Inc.
  • Bruker Corporation
  • Danaher Corporation
  • Eppendorf Ag
  • Ge Healthcare
  • Hitachi High-Technologies Corporation
  • Horiba Ltd.
  • Merck Kgaa
  • Perkinelmer, Inc.
  • Qiagen N.V.
  • Shimadzu Corporation
  • Thermo Fisher Scientific, Inc.
  • Waters Corporation

For more information about this report visit https://www.researchandmarkets.com/research/flt3fj/life_science

© Business Wire 2017
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news "Companies"
01:53a ACCESS BANK : Experts Call for Stringent Regulation for SIM Swap
01:53a ROCHE : First-ever breast cancer patient journey study in sub-Saharan Africa
01:52a MANCHESTER UNITED : Ferdinand sees Messi as best ever he played against
01:52a CAMBER ENERGY INC : UPDATED CORRECTION: Camber Energy, Inc. Sets Date For 2018 Annual Meeting of Stockholders
01:51a LOWE : Settlement reached in Lowe's case to lower property taxes in Calhoun County
01:49a WAL MART STORES : Markets back in action
01:45a MANCHESTER UNITED : Five issues in the Premier League this weekend
01:44a CONSUMER WATCHDOG : Hellenic mortgages included abusive clauses
01:44a Sorenson Holdings, LLC Commences Modified “Dutch Auction” Cash Tender Offer for Senior Unsecured PIK Toggle Notes due 2021
Latest news "Companies"